These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 32825392)
1. The Catalytic Cycle of the Antioxidant and Cancer-Associated Human NQO1 Enzyme: Hydride Transfer, Conformational Dynamics and Functional Cooperativity. Anoz-Carbonell E; Timson DJ; Pey AL; Medina M Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32825392 [TBL] [Abstract][Full Text] [Related]
3. A Dynamic Core in Human NQO1 Controls the Functional and Stability Effects of Ligand Binding and Their Communication across the Enzyme Dimer. Vankova P; Salido E; Timson DJ; Man P; Pey AL Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31726777 [TBL] [Abstract][Full Text] [Related]
4. Structural dynamics and functional cooperativity of human NQO1 by ambient temperature serial crystallography and simulations. Grieco A; Boneta S; Gavira JA; Pey AL; Basu S; Orlans J; Sanctis D; Medina M; Martin-Garcia JM Protein Sci; 2024 Apr; 33(4):e4957. PubMed ID: 38501509 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity. Megarity CF; Timson DJ Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515 [TBL] [Abstract][Full Text] [Related]
6. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Pey AL; Megarity CF; Timson DJ Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535 [TBL] [Abstract][Full Text] [Related]
7. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548 [TBL] [Abstract][Full Text] [Related]
8. H-tunneling in the multiple H-transfers of the catalytic cycle of morphinone reductase and in the reductive half-reaction of the homologous pentaerythritol tetranitrate reductase. Basran J; Harris RJ; Sutcliffe MJ; Scrutton NS J Biol Chem; 2003 Nov; 278(45):43973-82. PubMed ID: 12941965 [TBL] [Abstract][Full Text] [Related]
9. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.). Lienhart WD; Gudipati V; Uhl MK; Binter A; Pulido SA; Saf R; Zangger K; Gruber K; Macheroux P FEBS J; 2014 Oct; 281(20):4691-4704. PubMed ID: 25143260 [TBL] [Abstract][Full Text] [Related]
10. Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1). Lienhart WD; Strandback E; Gudipati V; Koch K; Binter A; Uhl MK; Rantasa DM; Bourgeois B; Madl T; Zangger K; Gruber K; Macheroux P FEBS J; 2017 Apr; 284(8):1233-1245. PubMed ID: 28236663 [TBL] [Abstract][Full Text] [Related]
11. Effects of the donor-acceptor distance and dynamics on hydride tunneling in the dihydrofolate reductase catalyzed reaction. Stojković V; Perissinotti LL; Willmer D; Benkovic SJ; Kohen A J Am Chem Soc; 2012 Jan; 134(3):1738-45. PubMed ID: 22171795 [TBL] [Abstract][Full Text] [Related]
12. Temperature-Independent Kinetic Isotope Effects as Evidence for a Marcus-like Model of Hydride Tunneling in Phosphite Dehydrogenase. Howe GW; van der Donk WA Biochemistry; 2019 Oct; 58(41):4260-4268. PubMed ID: 31535852 [TBL] [Abstract][Full Text] [Related]
13. Vibrationally enhanced hydrogen tunneling in the Escherichia coli thymidylate synthase catalyzed reaction. Agrawal N; Hong B; Mihai C; Kohen A Biochemistry; 2004 Feb; 43(7):1998-2006. PubMed ID: 14967040 [TBL] [Abstract][Full Text] [Related]
14. Thermodynamics of cooperative binding of FAD to human NQO1: Implications to understanding cofactor-dependent function and stability of the flavoproteome. Clavería-Gimeno R; Velazquez-Campoy A; Pey AL Arch Biochem Biophys; 2017 Dec; 636():17-27. PubMed ID: 29100982 [TBL] [Abstract][Full Text] [Related]
15. Solvent Effects on the Temperature Dependence of Hydride Kinetic Isotope Effects: Correlation to the Donor-Acceptor Distances. Adhikari P; Song M; Bai M; Rijal P; DeGroot N; Lu Y J Phys Chem A; 2022 Oct; 126(42):7675-7686. PubMed ID: 36228057 [TBL] [Abstract][Full Text] [Related]
16. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants. Rashid MH; Babu D; Siraki AG Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969 [TBL] [Abstract][Full Text] [Related]
17. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups. Mendoza MF; Hollabaugh NM; Hettiarachchi SU; McCarley RL Biochemistry; 2012 Oct; 51(40):8014-26. PubMed ID: 22989153 [TBL] [Abstract][Full Text] [Related]
18. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380 [TBL] [Abstract][Full Text] [Related]
19. NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms. Beaver SK; Mesa-Torres N; Pey AL; Timson DJ Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):663-676. PubMed ID: 31091472 [TBL] [Abstract][Full Text] [Related]
20. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]